<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04382183</url>
  </required_header>
  <id_info>
    <org_study_id>2020/50405</org_study_id>
    <nct_id>NCT04382183</nct_id>
  </id_info>
  <brief_title>Impact of Ketogenic Diets in Preventing Relapse in Obesity Management</brief_title>
  <acronym>Ketomaintain</acronym>
  <official_title>Evaluation of the Efficacy, Feasibility, and Safety of Ketogenic Diets in Preventing Relapse in Obesity Management</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Norwegian University of Science and Technology</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>St. Olavs Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Norwegian University of Science and Technology</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Low-carb ketogenic diets have become extremely popular because of large weight loss in the&#xD;
      short-term. Yet their potential benefits in preventing long-term weight regain have not been&#xD;
      assessed in large scale studies.&#xD;
&#xD;
      The aim of this study is to determine the effect of a low-carbohydrate (CHO) ketogenic diet,&#xD;
      compared with an isocaloric balanced diet, on the maintenance of weight loss. The secondary&#xD;
      aim is to investigate the impact of both diets on appetite. Adults with obesity (30&lt;BMI&lt;40&#xD;
      kg/m2), will first undergo 4 weeks of a very-low energy diet aimed at inducing 5-10% weight&#xD;
      loss and then will be randomized to two different weight maintenance diets for 1 year. One&#xD;
      will be a low-CHO ketogenic diet (50 g CHO/day) plant-based (e.g. with less animal protein&#xD;
      and more plant-based), and the other a diet following the Norwegian Health Directorate&#xD;
      recommendations. Only conventional foods will be used in both diets.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">August 3, 2020</start_date>
  <completion_date type="Anticipated">December 31, 2021</completion_date>
  <primary_completion_date type="Anticipated">December 31, 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Participant)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Body weight regain</measure>
    <time_frame>Body weight changes at 1-year intervention</time_frame>
    <description>Body weight will be measured at baseline, at week 5, at 6 months, and at 1 year</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Fasting lipid profile</measure>
    <time_frame>Lipid profile changes at 1-year intervention</time_frame>
    <description>Blood sampling in fasting to measure lipid profile (plasma concentration of total cholesterol, triglycerides, high-density lipids (HDL), low-density lipids (LDL) at baseline, at 6 months, and at 1 year</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Bone mineral density</measure>
    <time_frame>Bone mineral density changes at 1-year intervention</time_frame>
    <description>Bone mineral density will be measured by Dual-energy X-ray absorptiometry (DXA) at baseline, at 6 months, and at 1 year</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">108</enrollment>
  <condition>Obesity</condition>
  <arm_group>
    <arm_group_label>Ketogenic weight loss maintenance diet</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>The ketogenic weight loss maintenance group will undergo in a ketogenic diet (50 g CHO/day) plant-based for 1 year.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Isocaloric balanced weight loss maintenance diet</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>The isocaloric balanced weight loss maintenance group will undergo in a diet following the standard Norwegian Health Directorate recommendations for 1 year.</description>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Ketogenic weight loss maintenance diet</intervention_name>
    <description>The ketogenic weight loss maintenance group will undergo in a ketogenic diet (50 g CHO/day) plant-based for 1 year.</description>
    <arm_group_label>Ketogenic weight loss maintenance diet</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Isocaloric balanced weight loss maintenance diet</intervention_name>
    <description>The isocaloric balanced weight loss maintenance group will undergo in a diet following the recommendations from the Norwegian Health Directorate for 1 year.</description>
    <arm_group_label>Isocaloric balanced weight loss maintenance diet</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  weight stable over the last three months (&lt;2 kg)&#xD;
&#xD;
          -  not currently dieting to lose weight&#xD;
&#xD;
          -  inactive lifestyle (less than 150 min of physical activity weekly.&#xD;
&#xD;
          -  Given that some of the variables of interest have been shown to be affected by the&#xD;
             phase of menstrual cycle in normally ovulating women, namely appetite and resting&#xD;
             metabolic rate, only women taking oral contraceptives, with regular menstrual cycles&#xD;
             or post-menopausal will be included in the study&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  pregnancy&#xD;
&#xD;
          -  breast-feeding&#xD;
&#xD;
          -  drug or alcohol abuse within the last two years&#xD;
&#xD;
          -  clinically significant illness including diabetes, gastrointestinal (particularly&#xD;
             cholelithiasis), kidney (GFR &lt;60) or liver disease, osteoporosis (T-score &lt;-2.5) and&#xD;
             osteopenia (T-score &lt;-1.5)&#xD;
&#xD;
          -  treatment with antiosteoporotic drug&#xD;
&#xD;
          -  depression or other psychological disorders&#xD;
&#xD;
          -  eating disorders&#xD;
&#xD;
          -  milk intolerance&#xD;
&#xD;
          -  current medication known to affect appetite/metabolism or induce weight loss.&#xD;
&#xD;
          -  a planned surgery during the study period&#xD;
&#xD;
          -  participating in another research study&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Torstein Baade Rø, MD PhD</last_name>
    <role>Study Director</role>
    <affiliation>NTNU Faculty of Medicine and Health Sciences, IKOM</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Birger Henning Endreseth, Professor</last_name>
    <role>Study Director</role>
    <affiliation>St. Olvas Hospital</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Silvia Coutinho, PhD</last_name>
    <phone>+4798639859</phone>
    <email>silvia.coutinho@ntnu.no</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Cátia Martins, Professor</last_name>
    <phone>+4772825358</phone>
    <email>catia.martins@ntnu.no</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Forsyningssenteret at NTNU</name>
      <address>
        <city>Trondheim</city>
        <country>Norway</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Silvia Couthinho, PhD</last_name>
      <email>silvia.coutinho@ntnu.no</email>
    </contact>
  </location>
  <location_countries>
    <country>Norway</country>
  </location_countries>
  <verification_date>September 2021</verification_date>
  <study_first_submitted>April 28, 2020</study_first_submitted>
  <study_first_submitted_qc>May 6, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">May 11, 2020</study_first_posted>
  <last_update_submitted>September 26, 2021</last_update_submitted>
  <last_update_submitted_qc>September 26, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">October 1, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Diet, Ketogenic</keyword>
  <keyword>Weight Loss</keyword>
  <keyword>Body Weight</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Obesity</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

